You'll need to sign in to follow to this podcast.
New to Podcast Chart? Sign up.
May 18th, 2014
Episode 45 of 74 episodes
Stuart Roberts, Baillieu Holst - Australian life science stocks are well regarded but it’s a volatile sector. Biotech analyst Stuart Roberts explains why these four stocks have done well this year.
You'll need to sign in to write a comment.
You'll need to sign in to add this to your collection.
Podcast Chart © 2016 Project Fantastic Ltd